IN8bio Insider Trading Activity | NASDAQ:INAB

Comments

IN8bio Inc Insider Trading Activity

INABNASDAQ

Trade with Public

$1.44

-0.01-0.69%

At close: Apr 17, 5:00 PM EST

$1.40

-0.04-2.78%

After Hours: 9:03 AM EST

Overview News Earnings Analyst RatingsInsider TradesShort Interest Stock Report

IN8bio Insider Trading Activity | NASDAQ:INAB | Benzinga

Track the latest IN8bio insider trading activity. Stay informed on recent buys, sells, and market impact for IN8bio stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are IN8bio Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

There has been no Insider buying or selling in the last 90 days.

Ownership Statistics for IN8bio Inc

Shares Outstanding

9.847M

Shares Float

8797970.0%

Insider Shares Owned

486.870K

Insider Percentage Owned

4.99%

Institutional Shares Held

993.685K

Institutional Percentage Held

9.79%

Loading calendar...

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

INAB Insider Trading News

AIGH Capital Management Reported 9.4% Stake In IN8bio In 13G Filing

Charles Gross

$5 Million Bet On SoFi Technologies? Check Out These 5 Penny Stocks Insiders Are Buying

The Dow Jones closed higher by over 100 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

PEDEVCO, VerifyMe And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

The Dow Jones dipped by more than 450 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

$92 Million Bet On This Penny Stock? Also Check Out Other 3 Stocks Under $5 Insiders Are Buying

U.S. initial jobless claims dropped by 2,000 to 250,000 the week ended August 13th. Investors, meanwhile, focused on some notable insider trades.

Lisa Levin

PRO
IN8bio Reports In Form4 Filing Director Buys 1,773,684 Shares At Average Price Of $1.90/Share

-SEC Filing

Benzinga Newsdesk

People Also Watch

Quoin Pharmaceuticals Ltd

NASDAQ:QNRX

$6.58

1.86%

Cellectar Biosciences Inc

Intensity Therapeutics Inc

NASDAQ:INTS

$5.25

-0.94%

Barinthus Biotherapeutics PLC

NASDAQ:BRNS

$0.60

2.51%

Vistagen Therapeutics Inc

NASDAQ:VTGN

$0.63

0.37%

XTL Biopharmaceuticals Ltd

NASDAQ:XTLB

$2.45

Regentis Biomaterials Ltd

AMEX:RGNT

$3.05

-4.69%


Sep 15, 2023	Jeremy Graff	DIRECTOR	2.50K	$0.95	$2.38K	BUY	∞	2.50K	Sep 13	View
Aug 28, 2023	Patrick McCall	CHIEF FINANCIAL OFFICER	1.00K	$1.03	$1.03K	BUY	19.00%	6.26K	Aug 25	View
Aug 28, 2023	TaiWei William Ho	PRESIDENT AND CEO	23.80K	$1.05	$24.99K	BUY	1.01%	2.38M	Aug 24	View
Dec 13, 2022	Leslie Kreis Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC	DIRECTOR	75.00K	$2.48	$185.91K	BUY	5.02%	1.57M	Dec 12	View
Dec 13, 2022	GL Aaron Fletcher BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP BIOS Incysus CoInvest I LP BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP BIOS Capital Management LP BIOS Advisors GP LLC	DIRECTOR	75.00K	$2.48	$185.91K	BUY	5.02%	1.57M	Dec 12	View
Sep 29, 2022	GL Aaron Fletcher BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP BIOS Incysus CoInvest I LP BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP BIOS Capital Management LP BIOS Advisors GP LLC	DIRECTOR	25.00K	$2.02	$50.53K	BUY	1.63%	1.56M	Sep 28	View
Sep 29, 2022	Leslie Kreis Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC	DIRECTOR	25.00K	$2.02	$50.53K	BUY	1.63%	1.56M	Sep 28	View
Aug 30, 2022	GL Aaron Fletcher BIOS Fund II NT LP BIOS Fund II LP BIOS Fund II QP LP BIOS Incysus CoInvest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC	DIRECTOR	51.21K	$2.02	$103.34K	BUY	3.40%	1.56M	Aug 26 - Aug 29	View
Aug 30, 2022	Leslie Kreis BIOS Fund II NT LP BIOS Fund II LP BIOS Fund II QP LP BIOS Incysus CoInvest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC	DIRECTOR	51.21K	$2.02	$103.34K	BUY	3.40%	1.56M	Aug 26 - Aug 29	View
Aug 18, 2022	Leslie Kreis BIOS Fund II NT LP BIOS Fund II LP BIOS Fund II QP LP BIOS Incysus CoInvest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC	DIRECTOR	50.00K	$1.93	$96.50K	BUY	3.33%	1.55M	Aug 17	View
Aug 18, 2022	GL Aaron Fletcher BIOS Equity Partners III LP Cavu Management LP BIOS Capital Management LP BIOS Advisors GP LLC	DIRECTOR	50.00K	$1.93	$96.50K	BUY	3.33%	1.55M	Aug 17	View
Aug 18, 2022	EMILY FAIRBAIRN Transcend Partners Opportunity Fund LLC	DIRECTOR	789.47K	$1.90	$1.50M	BUY	23.57%	4.14M	Aug 16	View
Aug 18, 2022	TaiWei William Ho	PRESIDENT, CEO AND CFO	26.32K	$1.90	$50.00K	BUY	1.13%	2.35M	Aug 16	View
Aug 18, 2022	Kate Rochlin	CHIEF OPERATING OFFICER	5.26K	$1.90	$10.00K	BUY	∞	5.26K	Aug 16	View
Aug 18, 2022	Patrick McCall	CHIEF FINANCIAL OFFICER	5.26K	$1.90	$10.00K	BUY	∞	5.26K	Aug 16	View
Aug 18, 2022	Trishna Goswami	CHIEF MEDICAL OFFICER	2.63K	$1.90	$5.00K	BUY	∞	2.63K	Aug 16	View
Aug 18, 2022	Lawrence Lamb	EVP AND CSO	526.00	$1.90	$999.40	BUY	0.53%	99.73K	Aug 16	View
Aug 18, 2022	Luba Greenwood	DIRECTOR	526.00	$1.90	$999.40	BUY	7.21%	7.83K	Aug 16	View
Aug 18, 2022	Alan Roemer	DIRECTOR	26.32K	$1.90	$50.00K	BUY	88.68%	55.99K	Aug 16	View
Aug 18, 2022	Peter Brandt	DIRECTOR	105.26K	$1.90	$200.00K	BUY	57.68%	287.76K	Aug 16	View
Aug 17, 2022	Leslie Kreis BIOS Fund II NT LP BIOS Fund II LP BIOS Fund III QP LP BIOS Incysus CoInvest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC	DIRECTOR	1.77M	$1.90	$3.37M	BUY	∞	1.54M	Aug 16	View
Aug 17, 2022	GL Aaron Fletcher BIOS Equity Partners III LP Cavu Management LP BIOS Capital Management LP BIOS Advisors GP LLC	DIRECTOR	1.77M	$1.90	$3.37M	BUY	∞	1.54M	Aug 16	View
Aug 03, 2021	EMILY FAIRBAIRN Transcend Partners Opportunity Fund LLC	DIRECTOR	3.43M	$10.00	$1.00M	BUY	∞	3.32M	Aug 03	View


Sep 15, 2023	Jeremy Graff	DIRECTOR	2.50K	$0.95	$2.38K	BUY	∞	2.50K	Sep 13	View
Aug 28, 2023	Patrick McCall	CHIEF FINANCIAL OFFICER	1.00K	$1.03	$1.03K	BUY	19.00%	6.26K	Aug 25	View
Aug 28, 2023	TaiWei William Ho	PRESIDENT AND CEO	23.80K	$1.05	$24.99K	BUY	1.01%	2.38M	Aug 24	View
Dec 13, 2022	Leslie Kreis Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC	DIRECTOR	75.00K	$2.48	$185.91K	BUY	5.02%	1.57M	Dec 12	View
Dec 13, 2022	GL Aaron Fletcher BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP BIOS Incysus CoInvest I LP BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP BIOS Capital Management LP BIOS Advisors GP LLC	DIRECTOR	75.00K	$2.48	$185.91K	BUY	5.02%	1.57M	Dec 12	View
Sep 29, 2022	GL Aaron Fletcher BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP BIOS Incysus CoInvest I LP BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP BIOS Capital Management LP BIOS Advisors GP LLC	DIRECTOR	25.00K	$2.02	$50.53K	BUY	1.63%	1.56M	Sep 28	View
Sep 29, 2022	Leslie Kreis Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC	DIRECTOR	25.00K	$2.02	$50.53K	BUY	1.63%	1.56M	Sep 28	View
Aug 30, 2022	GL Aaron Fletcher BIOS Fund II NT LP BIOS Fund II LP BIOS Fund II QP LP BIOS Incysus CoInvest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC	DIRECTOR	51.21K	$2.02	$103.34K	BUY	3.40%	1.56M	Aug 26 - Aug 29	View
Aug 30, 2022	Leslie Kreis BIOS Fund II NT LP BIOS Fund II LP BIOS Fund II QP LP BIOS Incysus CoInvest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC	DIRECTOR	51.21K	$2.02	$103.34K	BUY	3.40%	1.56M	Aug 26 - Aug 29	View
Aug 18, 2022	Leslie Kreis BIOS Fund II NT LP BIOS Fund II LP BIOS Fund II QP LP BIOS Incysus CoInvest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC	DIRECTOR	50.00K	$1.93	$96.50K	BUY	3.33%	1.55M	Aug 17	View
Aug 18, 2022	GL Aaron Fletcher BIOS Equity Partners III LP Cavu Management LP BIOS Capital Management LP BIOS Advisors GP LLC	DIRECTOR	50.00K	$1.93	$96.50K	BUY	3.33%	1.55M	Aug 17	View
Aug 18, 2022	EMILY FAIRBAIRN Transcend Partners Opportunity Fund LLC	DIRECTOR	789.47K	$1.90	$1.50M	BUY	23.57%	4.14M	Aug 16	View
Aug 18, 2022	TaiWei William Ho	PRESIDENT, CEO AND CFO	26.32K	$1.90	$50.00K	BUY	1.13%	2.35M	Aug 16	View
Aug 18, 2022	Kate Rochlin	CHIEF OPERATING OFFICER	5.26K	$1.90	$10.00K	BUY	∞	5.26K	Aug 16	View
Aug 18, 2022	Patrick McCall	CHIEF FINANCIAL OFFICER	5.26K	$1.90	$10.00K	BUY	∞	5.26K	Aug 16	View
Aug 18, 2022	Trishna Goswami	CHIEF MEDICAL OFFICER	2.63K	$1.90	$5.00K	BUY	∞	2.63K	Aug 16	View
Aug 18, 2022	Lawrence Lamb	EVP AND CSO	526.00	$1.90	$999.40	BUY	0.53%	99.73K	Aug 16	View
Aug 18, 2022	Luba Greenwood	DIRECTOR	526.00	$1.90	$999.40	BUY	7.21%	7.83K	Aug 16	View
Aug 18, 2022	Alan Roemer	DIRECTOR	26.32K	$1.90	$50.00K	BUY	88.68%	55.99K	Aug 16	View
Aug 18, 2022	Peter Brandt	DIRECTOR	105.26K	$1.90	$200.00K	BUY	57.68%	287.76K	Aug 16	View
Aug 17, 2022	Leslie Kreis BIOS Fund II NT LP BIOS Fund II LP BIOS Fund III QP LP BIOS Incysus CoInvest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC	DIRECTOR	1.77M	$1.90	$3.37M	BUY	∞	1.54M	Aug 16	View
Aug 17, 2022	GL Aaron Fletcher BIOS Equity Partners III LP Cavu Management LP BIOS Capital Management LP BIOS Advisors GP LLC	DIRECTOR	1.77M	$1.90	$3.37M	BUY	∞	1.54M	Aug 16	View
Aug 03, 2021	EMILY FAIRBAIRN Transcend Partners Opportunity Fund LLC	DIRECTOR	3.43M	$10.00	$1.00M	BUY	∞	3.32M	Aug 03	View

Benzinga

Benzinga

IN8bio Inc Insider Trading Activity

IN8bio Insider Trading Activity | NASDAQ:INAB | Benzinga

What is Insider Activity?

What are IN8bio Inc Insiders Doing?

Notable Recent Insider Buys and Sales

Ownership Statistics for IN8bio Inc

FAQ

Is insider trading legal?

What are some examples of market manipulation?

INAB Insider Trading News

AIGH Capital Management Reported 9.4% Stake In IN8bio In 13G Filing

$5 Million Bet On SoFi Technologies? Check Out These 5 Penny Stocks Insiders Are Buying

PEDEVCO, VerifyMe And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

$92 Million Bet On This Penny Stock? Also Check Out Other 3 Stocks Under $5 Insiders Are Buying

PROIN8bio Reports In Form4 Filing Director Buys 1,773,684 Shares At Average Price Of $1.90/Share

People Also Watch

IN8bio Insider Trading Activity | NASDAQ:INAB | Benzinga

What is Insider Activity?

What are IN8bio Inc Insiders Doing?

Notable Recent Insider Buys and Sales

Ownership Statistics for IN8bio Inc

FAQ

Is insider trading legal?

What are some examples of market manipulation?

INAB Insider Trading News

AIGH Capital Management Reported 9.4% Stake In IN8bio In 13G Filing

$5 Million Bet On SoFi Technologies? Check Out These 5 Penny Stocks Insiders Are Buying

PEDEVCO, VerifyMe And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

$92 Million Bet On This Penny Stock? Also Check Out Other 3 Stocks Under $5 Insiders Are Buying

PROIN8bio Reports In Form4 Filing Director Buys 1,773,684 Shares At Average Price Of $1.90/Share

People Also Watch

PRO
IN8bio Reports In Form4 Filing Director Buys 1,773,684 Shares At Average Price Of $1.90/Share

PRO
IN8bio Reports In Form4 Filing Director Buys 1,773,684 Shares At Average Price Of $1.90/Share